benevir biopharma

Oncolytic immunotherapy startup BeneVir gets $3M

BeneVir's cancer vaccines are engineered to incite an immune response, as well as hide from the immune system - so as to have a prolonged anti-cancer effect.

By Meghana Keshavan

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.

BioPharma

BioLabs Pegasus Park Cultivates Life Science Ecosystem

Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.